[Collagen diseases with pulmonary hypertension].
Endo
Hirahito
H
Kitasato University School of Medicine, Department of Internal Medicine, Division of Rheumatology.
Tanaka
Sumiaki
S
Sakai
Miho
M
D000284:Administration, Oral; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003095:Collagen Diseases / Q000150:complications*; D016232:Endothelins / Q000627:therapeutic use; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology*; D007262:Infusions, Intravenous; D008297:Male; D008947:Mixed Connective Tissue Disease / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D016232:Endothelins; D011239:Prednisolone; D011464:Epoprostenol